Surgeons treating T1 ampullary cancer need to consider high upstaging rates and significant survival disparities based on pathologic classification. In this cohort of 244 T1 ampullary cancer patients, 75% underwent resection, but 68% were upstaged to higher T classifications post-surgery. Five-year overall survival rates were starkly different: 36% for clinical T1N0 vs. 75% for pathologic […]

A recent study highlights the critical need to adjust how we identify and manage chyle leak after pancreatic surgery. Chyle leak occurred in 11% of patients; risk factors included a minimally invasive approach and maximum drainage volume. Patients with high drainage volume (≥300 ml/day) and triglyceride-rich but non-milky drainage faced longer hospital stays (19 days) […]

Surgeons trained in dedicated hepato-pancreato-biliary fellowships see better patient outcomes after HP cancer surgeries. Graduates of HPB fellowships achieved a 47.7% likelihood of textbook outcomes (TOS), compared to 45.2% for surgical oncology and 42.8% for transplant fellowship graduates. Patients operated by HPB fellowship graduates often had higher comorbidity scores and greater urgencies, highlighting the need […]

High-volume hospitals improve survival and reduce costs for necrotizing pancreatitis patients. Patients at high-volume centers had lower odds of mortality (odds ratio: 0.78) compared to low-volume hospitals. Even with higher overall mortality rates, high-volume hospitals had lower mortality for intervention-only patients (7.5% vs 12.0%, p < 0.001). High-volume centers also associated with shorter hospital stays […]

Patient-derived organoid testing shows promise for tailoring therapy in pancreatic ductal adenocarcinoma. 91% of organoids matched to standard-of-care regimens, with 34% of poorly matched cases potentially qualifying for more effective options. Patients receiving well-matched neoadjuvant chemotherapy showed significantly better CA 19-9 response (60% normalization) and lymph node down-staging (69% N0) compared to poorly matched cases […]

An innovative algorithm from routine data can effectively classify 30-day postoperative complications in hepatobiliary surgery, helping surgeons better understand patient outcomes. Among 959 liver resections, the algorithm achieved an impressive macro-f1-score of 0.962 and a sensitivity of 0.950. Major complications were observed in 18% of cases, with a 2.6% mortality rate. This tool outperforms machine […]

A novel vascular occlusion method improves surgical outcomes in robotic enucleation of distal pancreatic tumors, crucial for better visualization and safety. Complete segmental parenchymal vascular occlusion creates a near-bloodless field, reducing the risk of main pancreatic duct injury. Postoperative outcomes show low morbidity and no cases of parenchymal ischemic necrosis. This technique enhances safety and […]

Surveillance for intraductal papillary mucinous neoplasms (IPMNs) reveals a tenfold increased risk of pancreatic adenocarcinoma compared to the general population. Cumulative incidence of malignancy at 60 months is 0.97%. The highest risk is associated with main pancreatic duct dilation ≥5 mm (SIR: 26.5) and BMI ≥30 (SIR: 20.6). Surgeons should consider personalizing surveillance strategies based […]

Median arcuate ligament (MAL) can significantly affect outcomes in pancreaticoduodenectomy (PD) patients. MAL stenosis occurred in 1.3% (115/8676), with hemodynamically significant cases in 0.7% (59 patients). Preoperative stenting was performed in 14%, while 83% underwent intraoperative division; 14% of divisions required vascular reconstruction due to failure. MAL management doesn’t worsen overall outcomes but demands early […]